ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2624

Evaluation of Asymptomatic Venous Disease By Venous Doppler Ultrasonography in Patients With Behcet’s Disease

Fatma Alibaz-Oner1, Emrah Karatay2, Ihsan Nuri Akpinar2, Tülin Ergun3 and Haner Direskeneli1, 1Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey, 2Radiology, Marmara University, School of Medicine, Istanbul, Turkey, 3Dermatology, Marmara University, School of Medicine, Istanbul, Turkey

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Behcet's syndrome

  • Tweet
  • Email
  • Print
Session Information

Title: Vasculitis III

Session Type: Abstract Submissions (ACR)

Background/Purpose: One of the major causes of mortality and morbidity in Behcet’s disease (BD), especially in young males of Mediterranean origin, is vascular involvement. A limited data suggests also a high prevelance of venous insufficiency (VI) and some cases of asymptomatic thrombosis in BD. In this study, we aimed to investigate prospectively asymptomatic venous  disease by venous doppler ultrasonography (US) in patients with BD  without known vascular disease.

Methods: The study included 93 patients with BD (M/F: 45/48, age: 36.4±10 years), 97 patients with ankylosing spondylitis (AS)(M/F: 50/47, age: 37.5±9.5 years) and 43 healthy control subjects (M/F: 25/18, age: 34.7±4.5 years). Vessels of both upper and lower extremities were examined while the subjects were in supine position by venous doppler US. CEAP severity score was used to evaluate the severity of the venous insuficiency.

Results: Upper extremity  veins were totally normal in all patients and controls. We also did not detect any “silent thrombosis” in study groups. Venous insufficiency findings in lower extremity were detected in 32.2% (n=30) in the BD group, 28.8% (n=28) in AS group and 9.3% (n=4) in the healthy control group. Both BD and AS patients had significantly higher VI rates than healthy controls (p=0.007 and 0.015). The rate of VI was similar between patients with BD and AS (p=0.64). Similarly, CEAP severity score in BD (0.34 (0-3))  was significantly higher than controls (0)(p=0.008), but similar to AS (0.18 (0-39)(p=0.18). No correlations were present between C-reactive protein elevations (>5 mg/L) and VI in patients with both BD (p=0.546) and AS (p=0.754).

Conclusion: A high prevelance of venous insufficiency was present in both BD and AS patients without asymptomatic thrombosis. Presence of VI also in AS, a disease without a major tendency to venous thrombosis, suggests that chronic inflammation might cause a mild insufficiency detected only by Power US in venous vessels. Long-term consequences of this finding requires further follow-up studies.

 


Disclosure:

F. Alibaz-Oner,
None;

E. Karatay,
None;

I. N. Akpinar,
None;

T. Ergun,
None;

H. Direskeneli,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-of-asymptomatic-venous-disease-by-venous-doppler-ultrasonography-in-patients-with-behcets-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology